Comirnaty

Comirnaty is the brand name for a COVID-19 vaccine developed by Pfizer and BioNTech. It uses messenger RNA (mRNA) technology to teach the immune system how to recognize and fight the virus that causes COVID-19. Once vaccinated, the body creates a response that helps protect against future infections. Comirnaty has been shown to reduce the risk of severe illness and hospitalization due to COVID-19. It is administered in a two-dose series, typically a few weeks apart, and has undergone rigorous testing to ensure its safety and effectiveness.